Tandem Diabetes Care, Inc. (TNDM)
USD 17.66
(-6.51%)
USD 17.66
(-6.51%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -233.23 Million USD | -277.34% |
| 2022 | -61.8 Million USD | -801.74% |
| 2021 | 8.8 Million USD | 210.69% |
| 2020 | -7.95 Million USD | 52.42% |
| 2019 | -16.72 Million USD | 62.53% |
| 2018 | -44.63 Million USD | 29.09% |
| 2017 | -62.94 Million USD | 19.36% |
| 2016 | -78.05 Million USD | -13.11% |
| 2015 | -69 Million USD | 8.8% |
| 2014 | -75.66 Million USD | -53.06% |
| 2013 | -49.43 Million USD | -49.58% |
| 2012 | -33.04 Million USD | -36.5% |
| 2011 | -24.21 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -30.77 Million USD | 26.16% |
| 2024 Q1 | -41.67 Million USD | -18.88% |
| 2023 Q3 | -31.54 Million USD | 18.72% |
| 2023 Q1 | -46.47 Million USD | -161.74% |
| 2023 FY | -233.23 Million USD | -277.34% |
| 2023 Q4 | -35.06 Million USD | -11.14% |
| 2023 Q2 | -38.8 Million USD | 16.49% |
| 2022 Q2 | -12.23 Million USD | 20.2% |
| 2022 Q4 | -17.75 Million USD | 62.62% |
| 2022 FY | -61.8 Million USD | -801.74% |
| 2022 Q1 | -15.33 Million USD | -232.09% |
| 2022 Q3 | -47.49 Million USD | -288.05% |
| 2021 Q4 | 11.61 Million USD | 50.41% |
| 2021 Q3 | 7.72 Million USD | 42.12% |
| 2021 Q1 | -3.23 Million USD | -117.35% |
| 2021 Q2 | 5.43 Million USD | 267.81% |
| 2021 FY | 8.8 Million USD | 210.69% |
| 2020 Q4 | 18.66 Million USD | 1949.55% |
| 2020 FY | -7.95 Million USD | 52.42% |
| 2020 Q3 | -1 Million USD | 91.62% |
| 2020 Q2 | -12.03 Million USD | 11.32% |
| 2020 Q1 | -13.57 Million USD | -733.07% |
| 2019 Q4 | 2.14 Million USD | 135.71% |
| 2019 FY | -16.72 Million USD | 62.53% |
| 2019 Q1 | -10.99 Million USD | -2063.75% |
| 2019 Q2 | -1.86 Million USD | 83.04% |
| 2019 Q3 | -6 Million USD | -221.93% |
| 2018 Q3 | -15.7 Million USD | -12.23% |
| 2018 Q2 | -13.99 Million USD | 9.61% |
| 2018 Q1 | -15.48 Million USD | -61.61% |
| 2018 FY | -44.63 Million USD | 29.09% |
| 2018 Q4 | 560 Thousand USD | 103.56% |
| 2017 Q2 | -18.96 Million USD | 10.64% |
| 2017 Q1 | -21.22 Million USD | -59.04% |
| 2017 FY | -62.94 Million USD | 19.36% |
| 2017 Q4 | -9.58 Million USD | 27.23% |
| 2017 Q3 | -13.16 Million USD | 30.58% |
| 2016 Q1 | -19.23 Million USD | -71.46% |
| 2016 FY | -78.05 Million USD | -13.11% |
| 2016 Q2 | -17.05 Million USD | 11.36% |
| 2016 Q4 | -13.34 Million USD | 53.03% |
| 2016 Q3 | -28.41 Million USD | -66.62% |
| 2015 Q2 | -18.67 Million USD | 8.52% |
| 2015 FY | -69 Million USD | 8.8% |
| 2015 Q3 | -18.7 Million USD | -0.17% |
| 2015 Q1 | -20.41 Million USD | -16.62% |
| 2015 Q4 | -11.22 Million USD | 40.01% |
| 2014 Q2 | -18.31 Million USD | 12.09% |
| 2014 FY | -75.66 Million USD | -53.06% |
| 2014 Q4 | -17.5 Million USD | 7.91% |
| 2014 Q3 | -19 Million USD | -3.75% |
| 2014 Q1 | -20.83 Million USD | -26.57% |
| 2013 Q3 | -12.12 Million USD | 11.33% |
| 2013 Q2 | -13.67 Million USD | -90.86% |
| 2013 Q1 | -7.16 Million USD | 14.7% |
| 2013 FY | -49.43 Million USD | -49.58% |
| 2013 Q4 | -16.46 Million USD | -35.75% |
| 2012 Q4 | -8.4 Million USD | 11.33% |
| 2012 Q3 | -9.47 Million USD | 0.0% |
| 2012 FY | -33.04 Million USD | -36.5% |
| 2011 FY | -24.21 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -1524.051% |
| Cerus Corporation | -30.05 Million USD | -676.062% |
| OrthoPediatrics Corp. | -25.76 Million USD | -805.185% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -2095.862% |
| Talis Biomedical Corporation | -66.81 Million USD | -249.068% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -1248.462% |
| Inogen, Inc. | -109.38 Million USD | -113.217% |
| Spectral AI, Inc. | -12.98 Million USD | -1696.288% |
| Nano-X Imaging Ltd. | -62.58 Million USD | -272.637% |
| CVRx, Inc. | -43.1 Million USD | -441.099% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -6510.828% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -1776.65% |
| Orthofix Medical Inc. | -139.11 Million USD | -67.659% |
| Venus Concept Inc. | -28.3 Million USD | -723.872% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | -331.684% |
| Bioventus Inc. | -81.72 Million USD | -185.384% |
| BrainsWay Ltd. | -4.92 Million USD | -4633.712% |
| Envoy Medical, Inc. | -18.37 Million USD | -1169.555% |
| electroCore, Inc. | -18.8 Million USD | -1140.255% |
| IceCure Medical Ltd | -15.57 Million USD | -1397.368% |
| Lucid Diagnostics Inc. | -48.48 Million USD | -381.065% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -1250.646% |
| MaxCyte, Inc. | -48.29 Million USD | -382.888% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -1850.858% |
| Nexalin Technology, Inc. | -5.69 Million USD | -3994.415% |
| PAVmed Inc | -68.79 Million USD | -239.022% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | -312.337% |
| RxSight, Inc. | -50.08 Million USD | -365.668% |
| Sight Sciences, Inc. | -57.27 Million USD | -307.218% |
| SI-BONE, Inc. | -46.93 Million USD | -396.964% |
| TELA Bio, Inc. | -44.07 Million USD | -429.166% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | -330.711% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | -353.508% |
| LivaNova PLC | -68.49 Million USD | -240.492% |
| 908 Devices Inc. | -42.75 Million USD | -445.465% |
| Alphatec Holdings, Inc. | -173.39 Million USD | -34.508% |
| Nemaura Medical Inc. | -9.59 Million USD | -2330.686% |
| NeuroPace, Inc. | -27.17 Million USD | -758.284% |
| LENSAR, Inc. | -12.22 Million USD | -1807.188% |
| Apyx Medical Corporation | -17.25 Million USD | -1251.353% |
| Cutera, Inc. | -156.23 Million USD | -49.286% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -2610.716% |
| BioSig Technologies, Inc. | -28.51 Million USD | -718.006% |
| Anika Therapeutics, Inc. | -87.63 Million USD | -166.126% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -939.072% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 309.126% |
| Axonics, Inc. | -26.05 Million USD | -795.076% |
| Outset Medical, Inc. | -169.77 Million USD | -37.38% |
| IRIDEX Corporation | -10 Million USD | -2230.669% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | -113.639% |
| IRadimed Corporation | 20.03 Million USD | 1264.086% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -2728.745% |
| INVO Bioscience, Inc. | -6.76 Million USD | -3346.5% |
| Telesis Bio, Inc. | -35.15 Million USD | -563.528% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 1727.565% |
| Varex Imaging Corporation | 32.1 Million USD | 826.573% |
| Quipt Home Medical Corp. | 3.91 Million USD | 6051.263% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -1822.278% |
| Pulmonx Corporation | -61.93 Million USD | -276.572% |
| Dynatronics Corporation | -2.27 Million USD | -10160.672% |
| Modular Medical, Inc. | -17.52 Million USD | -1230.538% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -1493.21% |
| Semler Scientific, Inc. | 22.25 Million USD | 1147.942% |
| InMode Ltd. | 195.66 Million USD | 219.202% |
| Bruker Corporation | 436.9 Million USD | 153.383% |
| Cytosorbents Corporation | -31.2 Million USD | -647.31% |
| DexCom, Inc. | 597.7 Million USD | 139.021% |
| Align Technology, Inc. | 643.33 Million USD | 136.253% |
| Viveve Medical, Inc. | -21.55 Million USD | -982.123% |
| ZimVie Inc. | -30.93 Million USD | -653.838% |
| Movano Inc. | -29.69 Million USD | -685.551% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -737.601% |
| Nexalin Technology, Inc. | -5.69 Million USD | -3994.415% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -6510.828% |
| Profound Medical Corp. | -28.61 Million USD | -715.034% |
| Insulet Corporation | 220 Million USD | 206.014% |
| enVVeno Medical Corporation | -25.23 Million USD | -824.122% |
| Surmodics, Inc. | -5.64 Million USD | -4031.621% |
| iCAD, Inc. | -7.68 Million USD | -2933.294% |
| Nuwellis, Inc. | -17.63 Million USD | -1222.915% |
| Biotricity, Inc. | -8.82 Million USD | -2541.854% |
| iRhythm Technologies, Inc. | -125.16 Million USD | -86.344% |
| Aethlon Medical, Inc. | -12.63 Million USD | -1745.675% |
| InspireMD, Inc. | -21.14 Million USD | -1003.107% |
| PAVmed Inc. | -68.79 Million USD | -239.022% |
| BIOLASE, Inc. | -17.93 Million USD | -1200.273% |
| Beyond Air, Inc. | -63 Million USD | -270.171% |
| FONAR Corporation | 16.53 Million USD | 1510.492% |
| AxoGen, Inc. | -21.46 Million USD | -986.711% |
| Vivani Medical, Inc. | -26.96 Million USD | -764.936% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 1392.778% |
| Inari Medical, Inc. | -14.03 Million USD | -1562.129% |
| UFP Technologies, Inc. | 57.66 Million USD | 504.464% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -4633.136% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -3598.676% |
| Tenon Medical, Inc. | -15.72 Million USD | -1382.991% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -3020.551% |
| Co-Diagnostics, Inc. | -42.7 Million USD | -446.126% |
| AdaptHealth Corp. | -598.4 Million USD | 61.024% |
| Sintx Technologies, Inc. | -13.35 Million USD | -1645.995% |
| NanoVibronix, Inc. | -3.43 Million USD | -6687.835% |
| Quanterix Corporation | -49.7 Million USD | -369.266% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -1822.278% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -60954.974% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 30.268% |
| TransMedics Group, Inc. | -28.72 Million USD | -711.884% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -887.76% |
| NeuroMetrix, Inc. | -7.15 Million USD | -3161.264% |
| Hyperfine, Inc. | -48.11 Million USD | -384.734% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | -258.672% |
| Biomerica, Inc. | -6.36 Million USD | -3563.107% |
| Bone Biologics Corporation | -9.42 Million USD | -2373.722% |
| AVITA Medical, Inc. | -40.4 Million USD | -477.272% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -2161.906% |
| Silk Road Medical, Inc | -59.27 Million USD | -293.498% |